BTEC:LSE-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (USD)

ETF | Others | LSE

Last Closing Price

USD 6.42

Change

0.00 (0.00)%

Market Cap

USD 0.32B

Volume

0.06M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Company Website : http://www.blackrock.com

Currency: USD

Country : UK

Management Expense Ratio: 0.35 %

Technical Indicators

Beta : 1.00

52 Week High : 6.64

52 Week Low : 2.57

200 Day Moving Average : 4.93

50 Day Moving Average : 5.37

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
AMGN Amgen Inc 7.56 %
GILD Gilead Sciences, Inc 5.89 %
VRTX Vertex Pharmaceuticals Incorporated 5.02 %
ILMN Illumina, Inc 4.30 %
REGN Regeneron Pharmaceuticals, Inc 4.22 %
MRNA Moderna, Inc 4.02 %
BIIB Biogen Inc 3.16 %
SGEN Seagen Inc 2.84 %
ALXN Alexion Pharmaceuticals, Inc 2.76 %
AZN AstraZeneca PLC 1.95 %
Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Morningstar Ratio : 4

Category Benchmark : NASDAQ Biotechnology TR USD

Sustainability Ratio : 3

3 Year Volatility : 23.05

3 Year Expected Return : 0.00

3 Year Sharpe Ratio : 0.55

YTD Return : 8.07%

3 Year Returns : 25.16%

5 Year Returns : 0.00%

10 Year Returns : 0.00%

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-07 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
CNKY:LSE iShares VII PLC - iShares Nikk.. 0.48 %

N/A

 USD36.37B
VUSD:LSE Vanguard S&P 500 UCITS ETF 0.00 %

N/A

 USD28.20B
VUSA:LSE Vanguard S&P 500 UCITS ETF 0.00 %

N/A

 USD26.04B
EMIM:LSE iShares Core MSCI EM IMI UCITS.. 0.18 %

N/A

 USD13.76B
SGLN:LSE iShares Physical Gold ETC 0.25 %

N/A

 USD12.94B
EIMU:LSE iShares Core MSCI EM IMI UCITS.. 0.18 %

N/A

 USD12.77B
EIMI:LSE iShares Core MSCI EM IMI UCITS.. 0.18 %

N/A

 USD12.77B
IDUS:LSE iShares Core S&P 500 UCITS ETF.. 0.07 %

N/A

 USD11.67B
SGLP:LSE Invesco Physical Gold ETC 0.24 %

N/A

 USD11.44B
IUSA:LSE iShares Core S&P 500 UCITS.. 0.07 %

N/A

 USD10.39B

ETFs Containing BTEC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.35% 11% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.35% 11% F 15% F
Trailing 12 Months  
Capital Gain 22.21% 70% C- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.21% 70% C- 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.57% 61% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.57% 60% D- 57% F
Risk Return Profile  
Volatility (Standard Deviation) 14.87% 37% F 62% D-
Risk Adjusted Return 50.89% 58% F 67% D+
Market Capitalization 0.32B 62% D- 63% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.